Concepedia

Al Elbendary

AE

Statistics

Publications

4

Citations

304

H-Index

4

Active since

1994

Affiliations

Duke Medical Center(Current)

Al Elbendary is an author at Duke Medical Center specializing in oncology, medicine, and ovarian cancer.

Publications per year

1994–2008

4

Publications

4

Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

Al Elbendary, Andrew Berchuck, P Davis et al. · PubMed · 1994 · 149 citations

Life Sciences, Cell Biology, Oncology +17

Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells.

Al Elbendary, Frank D. Cirisano, Anthony C. Evans et al. · PubMed · 1996 · 83 citations

Medicine, Cancer Biology, Oncology +16

Pathogenesis of Ovarian Cancers

Andrew Berchuck, Al Elbendary, L. Havrilesky et al. · Journal of the Society for Gynecologic Investigation · 1994 · 45 citations

Medicine, Gynecology, Oncology +12

A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer

Howard D. Homesley, Nathan P. Meltzer, Lucybeth Nieves et al. · International Journal of Clinical Oncology · 2008 · 27 citations

Medicine, Oncology, Pharmacology +11

1–4 of 4